ED pharmacist monitoring of provider antibiotic selection aids appropriate treatment for outpatient UTI

American Journal of Emergency Medicine

Volumn 34, Issue 8, 2016, Pages 1600-1603

  Lingenfelter, Erin ^a   Drapkin, Zachary ^b   Fritz, Kelly ^a   Youngquist, Scott ^b   Madsen, Troy ^b   Fix, Megan ^b  

^a UNIVERSITY OF UTAH   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT;

ADOLESCENT; ADULT; AGED; DRUG MONITORING; FEMALE; HOSPITAL EMERGENCY SERVICE; HUMAN; MALE; MIDDLE AGED; OUTPATIENT; PHARMACIST; PROCEDURES; RETROSPECTIVE STUDY; URINARY TRACT INFECTIONS; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; DRUG MONITORING; EMERGENCY SERVICE, HOSPITAL; FEMALE; HUMANS; MALE; MIDDLE AGED; OUTPATIENTS; PHARMACISTS; RETROSPECTIVE STUDIES; URINARY TRACT INFECTIONS; YOUNG ADULT;

EID: 84973541117     PISSN: 07356757     EISSN: 15328171     Source Type: Journal    
DOI: 10.1016/j.ajem.2016.05.076     Document Type: Article

References (17)

1. [1] Gupta, K, Hooton, TM, Naber, KG, Wullt, B, Colgan, R, Miller, LG, et al. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis 52:5 (2011), e103–e120.
2. [2] Stamm, WE, Scientific and clinical challenges in the management of urinary tract infections. Am J Med 113:Suppl. 1A (2002), 1S–4S.
3. [3] Guneysel, O, Onur, O, Erdede, M, Denizbasi, A, Trimethoprim/sulfamethoxazole resistance in urinary tract infections. J Emerg Med 36:4 (2009), 338–341.
4. [4] Binkley, S, Fishman, NO, LaRosa, LA, Marr, AM, Nachamkin, I, Wordell, D, et al. Comparison of unit-specific and hospital-wide antibiograms: potential implications for selection of empirical antimicrobial therapy. Infect Control Hosp Epidemiol 27:7 (2006), 682–687.
5. [5] Kaufman, D, Haas, CE, Edinger, R, Hollick, G, Antibiotic susceptibility in the surgical intensive care unit compared with the hospital-wide antibiogram. Arch Surg 133:10 (1998), 1041–1045.
6. [6] Nicolle, LE, Bradley, S, Colgan, R, Rice, JC, Schaeffer, A, Hooton, TM, et al. Infectious Diseases Society of America guidelines for the diagnosis and treatment of asymptomatic bacteriuria in adults. Clin Infect Dis 40:5 (2005), 643–654.
7. [7] Ronald, A, The etiology of urinary tract infection: traditional and emerging pathogens. Am J Med 113:Suppl. 1A (2002), 14S–19S.
8. [8] Khawcharoenporn, T, Vasoo, S, Ward, E, Singh, K, High rates of quinolone resistance among urinary tract infections in the ED. Am J Emerg Med 30:1 (2012), 68–74.
9. [9] Moffett, SE, Frazee, BW, Stein, JC, Navab, B, Maselli, J, Takhar, SS, et al. Antimicrobial resistance in uncomplicated urinary tract infections in 3 California EDs. Am J Emerg Med 30:6 (2012), 942–949.
10. [10] Shaifali, I, Gupta, U, Mahmood, SE, Ahmed, J, Antibiotic susceptibility patterns of urinary pathogens in female outpatients. N Am J Med Sci 4:4 (2012), 163–169.
11. [11] Qi, C, Pilla, V, Yu, JH, Reed, K, Changing prevalence of Escherichia coli with CTX-M-type extended-spectrum beta-lactamases in outpatient urinary E. coli between 2003 and 2008. Diagn Microbiol Infect Dis 67:1 (2010), 87–91.
12. [12] Pitout, JD, Nordmann, P, Laupland, KB, Poirel, L, Emergence of Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs) in the community. J Antimicrob Chemother 56:1 (2005), 52–59.
13. [13] Johnson, JR, Johnston, B, Clabots, C, Kuskowski, MA, Castanheira, M, Escherichia coli sequence type ST131 as the major cause of serious multidrug-resistant E. coli infections in the United States. Clin Infect Dis 51:3 (2010), 286–294.
14. [14] May, L, Cosgrove, S, L'Archeveque, M, Talan, DA, Payne, P, Jordan, J, et al. A call to action for antimicrobial stewardship in the emergency department: approaches and strategies. Ann Emerg Med 62:1 (2013), 69–77.e62.
15. [15] Karlowsky, JA, Kelly, LJ, Thornsberry, C, Jones, ME, Sahm, DF, Trends in antimicrobial resistance among urinary tract infection isolates of Escherichia coli from female outpatients in the United States. Antimicrob Agents Chemother 46:8 (2002), 2540–2545.
16. [16] Gross, PA, Patel, B, Reducing antibiotic overuse: a call for a national performance measure for not treating asymptomatic bacteriuria. Clin Infect Dis 45:10 (2007), 1335–1337.
17. [17] Lin, K, Fajardo, K, Force USPST, Screening for asymptomatic bacteriuria in adults: evidence for the U.S. Preventive Services Task Force reaffirmation recommendation statement. Ann Intern Med 149:1 (2008), W20–W24.